Methylene Chloride

Methylene Chloride

SCHEMBL8109620

CO.ClCCl.[Na+].[OH-]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Methylene Chloride. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0539380-B1 METHOD FOR THE PREPARATION AND PURIFICATION OF A MIXTURE OF GLYCOSPHINGOLIPIDS FREE FROM CONTAMINATION BY NON-CONVENTIONAL VIRUSES FIDIA SPA (IT) 2000-08-09 EP disclosed
EP-0652778-B1 BIODEGRADABLE GUIDE CHANNELS FOR USE IN TISSUE REPAIR AS SURGICAL AIDS FIDIA SPA (IT) 2000-03-15 EP disclosed
CN-1228090-A Naphthyridines with affect IL-4 and G-CSF SCHERING CORP (US) 1999-09-08 CN disclosed
EP-0454818-B1 METHOD FOR THE PREPARATION AND PURIFICATION OF A MIXTURE OF GLYCOSPHINGOLIPIDS FREE FROM CONTAMINATION BY NON-CONVENTIONAL VIRUSES FIDIA SPA (IT) 1998-08-19 EP disclosed
US-5521164-A GANGLIOSIDES FIDIA, S.P.A. (IT) 1996-05-28 US disclosed
EP-0539380-A1 METHOD FOR THE PREPARATION AND PURIFICATION OF A MIXTURE OF GLYCOSPHINGOLIPIDS FREE FROM CONTAMINATION BY NON-CONVENTIONAL VIRUSES FIDIA S.p.A. (IT) 1993-05-05 EP disclosed
WO-1992020695-A1 METHOD FOR THE PREPARATION AND PURIFICATION OF A MIXTURE OF GLYCOSPHINGOLIPIDS FREE FROM CONTAMINATION BY NON-CONVENTIONAL VIRUSES FIDIA S.P.A. (IT) 1992-11-26 WO disclosed
EP-0454818-A1 METHOD FOR THE PREPARATION AND PURIFICATION OF A MIXTURE OF GLYCOSPHINGOLIPIDS FREE FROM CONTAMINATION BY NON-CONVENTIONAL VIRUSES FIDIA S.p.A. (IT) 1991-11-06 EP disclosed
WO-1991007417-A1 METHOD FOR THE PREPARATION AND PURIFICATION OF A MIXTURE OF GLYCOSPHINGOLIPIDS FREE FROM CONTAMINATION BY NON-CONVENTIONAL VIRUSES FIDIA S.P.A. (IT) 1991-05-30 WO disclosed
US-4943566-A ANTAGONISTIC TOWARD GLUCOCORTICOIDS AND PROGESTERONE ROUSSEL UCLAFI 1990-07-24 US disclosed